September 26 2023

Meg Smith Named CEO of Cure Alzheimer’s Fund

Presentation by Laura Cox, Ph.D. – The Potential for Harnessing the Microbiome to Prevent and Treat Alzheimer’s Disease

Presentation by Dr. Ali Ezzati: Artificial Intelligence in Clinical Research of Alzheimer’s disease

July 7 2023

FDA AWARDS FULL APPROVAL FOR LEQEMBI

April 27 2023

Update on Alzheimer’s Disease by Rudy Tanzi, Ph.D.

February 23 2023

Orveon

February 14 2023

CUREALZ APPOINTS DRS. JOHN S. LAZO AND PATRICK C. MAY TO RESEARCH STRATEGY COUNCIL

January 8 2023

EISAI and BIOGEN ANNOUNCE TOP-LINE RESULTS OF LECANEMAB

December 13 2022

CURE ALZHEIMER’S FUND NOW ACCEPTS CRYPTOCURRENCY

December 1 2022

CUREALZ RECEIVES $30,000 GRANT FROM GREATER TOLEDO COMMUNITY FOUNDATION

October 7 2022

BLOOD PRESSURE MEDICATION: A FUTURE TREATMENT FOR AD?

October 7 2022

ALTERING THE GUT MICROBIOME IMPACTS AMYLOID IN THE BRAIN